Cancer Patients Clinical Trials

84 recruitingLast updated: June 19, 2026

There are 84 actively recruiting cancer patients clinical trials across 25 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Guangzhou, Guangdong, China, Harrison, New York, United States. Updated daily from ClinicalTrials.gov.


Cancer Patients Trials at a Glance

84 actively recruiting trials for cancer patients are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Not Applicable with 29 trials, with the heaviest enrollment activity in New York, Guangzhou, and Harrison. Lead sponsors running cancer patients studies include Memorial Sloan Kettering Cancer Center, Sun Yat-sen University, and Henan Cancer Hospital.

Browse cancer patients trials by phase

Treatments under study

About Cancer Patients Clinical Trials

Looking for clinical trials for Cancer Patients? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer Patients trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer Patients clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 84 trials

Recruiting

Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

Cancer PatientsLiver InjurySecondary to Immune Checkpoint Inhibitors
University Hospital, Montpellier250 enrolled1 locationNCT06864481
Recruiting

Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Cancer Patients
Memorial Sloan Kettering Cancer Center347 enrolled11 locationsNCT01742143
Recruiting
Not Applicable

Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients

Breast CancerBreast NeoplasmSymptom Management+4 more
Dena h. Al-Tameemi130 enrolled1 locationNCT07273812
Recruiting
Not Applicable

Cancer Survivors Program

Breast Cancer PatientsProstate Cancer Patients
Masaryk Memorial Cancer Institute200 enrolled1 locationNCT07253987
Recruiting
Not Applicable

Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision

Rectal Cancer PatientsRobotic Assisted Intervention
Sun Yat-sen University216 enrolled1 locationNCT07651553
Recruiting
Phase 2

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Rectal Cancer Stage IIRectal Cancer Stage IIIRectal Cancer Patients
Sixth Affiliated Hospital, Sun Yat-sen University236 enrolled1 locationNCT07176182
Recruiting
Phase 4

Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients

Cancer Patients
Beni-Suef University100 enrolled1 locationNCT07598214
Recruiting

SpaceOAR Post-Market Registry Study

Prostate Cancer Patients Treated by Radiotherapy
Sheffield Teaching Hospitals NHS Foundation Trust320 enrolled7 locationsNCT07300631
Recruiting
Not Applicable

Writing Intervention With Adolescents and Young Adults With Cancer

Cancer PatientsCommunication Research
St. Jude Children's Research Hospital26 enrolled1 locationNCT05975333
Recruiting

Evaluation of Gynecological and Sexual Sequelae

Rectal Cancer Patients
University Hospital, Rouen15 enrolled1 locationNCT07389863
Recruiting
Phase 3

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

Rectal CancerRectal Cancer Patients
Shandong Cancer Hospital and Institute210 enrolled1 locationNCT06850090
Recruiting
Phase 2

Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.

Rectal Cancer Patients
Sun Yat-sen University88 enrolled1 locationNCT06911684
Recruiting
Not Applicable

A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer

Adult cancer patientsRight Atrial Clot
Memorial Sloan Kettering Cancer Center150 enrolled7 locationsNCT07549477
Recruiting
Not Applicable

Prevention of CIPN Using Compressive Therapy

CIPN in Adjuvant Breast Cancer Patients
Martina Lojova100 enrolled1 locationNCT06823440
Recruiting
Phase 2

Pinoxin for the Prevention of Radiation-Induced Skin Injury

Cancer Patients Undergoning Radiotherapy
Fudan University202 enrolled2 locationsNCT07545720
Recruiting

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

Prostate CancerProstate Cancer MetastaticProstate Cancer (Adenocarcinoma)+3 more
Société Algérienne de Formation et Recherche en Oncologie2,000 enrolled24 locationsNCT07484971
Recruiting
Not Applicable

Mindfulness-Oriented Respiratory Distress Symptom Intervention for Lung Cancer

Symptom ClusterBreathlessnessCoughing+3 more
The Hong Kong Polytechnic University64 enrolled1 locationNCT07281300
Recruiting
Not Applicable

The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy

Breast Cancer PatientsChemotherapy-induced Peripheral Neuropathy (CIPN)Paclitaxel-induced Peripheral Neuropathy
Tuba Eryiğit30 enrolled1 locationNCT06964802
Recruiting
Phase 3

64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer

Prostate CancerCryotherapyProstate Cancer Recurrent+3 more
Clarity Pharmaceuticals Ltd220 enrolled28 locationsNCT06970847
Recruiting
Phase 1

TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy

Metastatic Castration-Resistant Prostate Cancer Patients
Tasly Pharmaceutical Group Co., Ltd78 enrolled1 locationNCT07514065